Insider Transactions in Q2 2025 at Willis Towers Watson PLC (WTW)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 03
2025
|
Andrew Jay Krasner Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
1,600
-11.78%
|
$504,000
$315.75 P/Share
|
May 15
2025
|
Inga K Beale Director |
BUY
Grant, award, or other acquisition
|
Direct |
709
+23.86%
|
-
|
May 15
2025
|
Inga K Beale Director |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-20.96%
|
$124,836
$303.37 P/Share
|
May 15
2025
|
Jacqueline Hunt Director |
BUY
Grant, award, or other acquisition
|
Direct |
709
+29.59%
|
-
|
May 15
2025
|
Jacqueline Hunt Director |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-29.64%
|
$124,836
$303.37 P/Share
|
May 15
2025
|
Michael P. Hammond Director |
BUY
Grant, award, or other acquisition
|
Direct |
709
+23.86%
|
-
|
May 15
2025
|
Michael P. Hammond Director |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-20.96%
|
$124,836
$303.37 P/Share
|
May 15
2025
|
Stephen M. Chipman Director |
BUY
Grant, award, or other acquisition
|
Direct |
709
+29.59%
|
-
|
May 15
2025
|
Stephen M. Chipman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-29.64%
|
$124,836
$303.37 P/Share
|
May 15
2025
|
Fumbi F. Chima Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,112
+24.48%
|
-
|
May 15
2025
|
Fumbi F. Chima Director |
SELL
Payment of exercise price or tax liability
|
Direct |
646
-21.79%
|
$195,738
$303.37 P/Share
|
May 15
2025
|
Paul D Thomas Director |
SELL
Payment of exercise price or tax liability
|
Direct |
600
-4.4%
|
$181,800
$303.37 P/Share
|
May 15
2025
|
Fredric J Tomczyk Director |
BUY
Grant, award, or other acquisition
|
Direct |
709
+29.59%
|
-
|
May 15
2025
|
Fredric J Tomczyk Director |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-29.64%
|
$124,836
$303.37 P/Share
|
May 15
2025
|
Paul C Reilly Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,032
+30.76%
|
-
|
May 15
2025
|
Paul C Reilly Director |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-24.19%
|
$124,836
$303.37 P/Share
|
May 15
2025
|
Michelle R Swanback Director |
BUY
Grant, award, or other acquisition
|
Direct |
709
+23.86%
|
-
|
May 15
2025
|
Michelle R Swanback Director |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-20.96%
|
$124,836
$303.37 P/Share
|
May 08
2025
|
Alexis Faber Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
265
-3.21%
|
$81,090
$306.92 P/Share
|
May 08
2025
|
Carl Aaron Hess Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,000
-2.15%
|
$3,080,000
$308.79 P/Share
|
Apr 21
2025
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
64
-0.07%
|
$21,568
$337.95 P/Share
|
Apr 21
2025
|
Pamela Thomson Hall Head of International |
SELL
Payment of exercise price or tax liability
|
Direct |
2
-0.03%
|
$674
$337.95 P/Share
|
Apr 21
2025
|
Andrew Jay Krasner Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12
-0.3%
|
$4,044
$337.95 P/Share
|
Apr 21
2025
|
Imran Ahmed Qureshi Head of North America |
SELL
Payment of exercise price or tax liability
|
Direct |
7
-0.09%
|
$2,359
$337.95 P/Share
|
Apr 21
2025
|
Anne Pullum Head of Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
9
-0.05%
|
$3,033
$337.95 P/Share
|
Apr 21
2025
|
Joseph Stephen Kurpis PAO and Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1
-0.08%
|
$337
$337.95 P/Share
|
Apr 21
2025
|
Kristy D Banas Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4
-0.05%
|
$1,348
$337.95 P/Share
|
Apr 21
2025
|
Alexis Faber Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4
-0.05%
|
$1,348
$337.95 P/Share
|
Apr 21
2025
|
Matthew Furman General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7
-0.02%
|
$2,359
$337.95 P/Share
|
Apr 21
2025
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Payment of exercise price or tax liability
|
Direct |
10
-0.01%
|
$3,370
$337.95 P/Share
|
Apr 20
2025
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,619
+6.45%
|
-
|
Apr 20
2025
|
Pamela Thomson Hall Head of International |
BUY
Grant, award, or other acquisition
|
Direct |
790
+11.93%
|
-
|
Apr 20
2025
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,180
+35.1%
|
-
|
Apr 20
2025
|
Imran Ahmed Qureshi Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
787
+9.05%
|
-
|
Apr 20
2025
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
851
+4.57%
|
-
|
Apr 20
2025
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
81
+6.3%
|
-
|
Apr 20
2025
|
Kristy D Banas Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
712
+7.8%
|
-
|
Apr 20
2025
|
Alexis Faber Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
783
+8.67%
|
-
|
Apr 20
2025
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
844
+2.33%
|
-
|
Apr 20
2025
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
1,681
+2.29%
|
-
|
Apr 20
2025
|
Lucy Clarke President of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
1,422
+7.5%
|
-
|
Apr 15
2025
|
Imran Ahmed Qureshi Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.22%
|
-
|
Apr 15
2025
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
140
+0.16%
|
-
|
Apr 15
2025
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
20
+0.12%
|
-
|
Apr 15
2025
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30
+1.59%
|
-
|
Apr 15
2025
|
Alexis Faber Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11
+0.15%
|
-
|
Apr 15
2025
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.04%
|
-
|
Apr 15
2025
|
Lucy Clarke President of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
37
+0.23%
|
-
|
Apr 15
2025
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
23
+0.03%
|
-
|
Apr 15
2025
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1
+0.09%
|
-
|